Schizophrenia Related Content

Emily E. Carol, PhD, is the clinic director of the Support, Treatment, and Resilience (STAR) Program at McLean Hospital. In this role, she is involved in STAR’s clinical, outreach, research, and training initiatives. Her expertise is in early identification and intervention for emerging serious...

Ann K. Shinn, MD, MPH, is the director of clinical research in the Schizophrenia and Bipolar Disorder Research Program, and an assistant professor of psychiatry at Harvard Medical School. From 2013-2017, she was the co-medical director of McLean OnTrack, an intensive outpatient program specializing...

Anna W. Sromek, PhD, received her BS in chemistry at the University of Chicago in 1996, and PhD in organic chemistry at the University of Illinois at Chicago in 2005. She was a NIDA post-doctoral research fellow at McLean Hospital from 2008 to 2010, and a recipient of the Alfred Pope Award for Young...

Young Cha, PhD, received his PhD in stem cell biology from CHA University in Korea. During his PhD studies, his scientific interest was to identify novel factors which are involved in the maintenance of self-renewality and pluripotency of embryonic stem cells. He joined the Molecular Neurobiology...

Dr. Lee has worked on numerous drug discovery projects related to traditional Chinese medicine, contributing significantly to the development of alternative therapies for substance misuse and for osteoarthritis. He is the principal investigator on “Alternative Therapies for Alcohol and Drug Abuse,”...

Cagri Yuksel, MD, is an assistant neuroscientist in the Schizophrenia and Bipolar Disorder Research Program and an associate professor of psychiatry at Harvard Medical School. His current research focus is studying brain bioenergetics in psychotic disorders using neuroimaging methods. Dr. Yuksel is...

Xi Chen, PhD, was trained in magnetic resonance physics, especially magnetic resonance spectroscopy (MRS) sequence development, during his PhD. Since joining the National Institute on Drug Abuse, his research interest has been on the development and application of advanced MRI/MRS techniques in...

Stephanie C. Valcourt, MD, is the medical director of McLean’s Schizophrenia and Bipolar Disorder Inpatient Program and an instructor in psychiatry at Harvard Medical School. With a medical degree from Georgetown University School of Medicine, she completed her psychiatry residency at the MGH/McLean...

Lauren V. Moran, MD, MPH, is the director of the McLean Pharmacoepidemiology Laboratory, part of the Advanced Bioinformatics and Computational Discovery Hub. She is also an attending psychiatrist with the Schizophrenia and Bipolar Disorder Inpatient Program. Dr. Moran’s research currently focuses...

Erin B. Sandler, LICSW, joined McLean Hospital in 2013, working at Appleton House as a clinical team manager. Previously, she had worked for over five years with individuals living with post-traumatic stress disorder, bipolar disorder, and psychosis as an outreach social worker contracted through...

Perihan Esra Guvenek-Cokol, MD, is a double board certified child, adolescent, and adult psychiatrist. She specializes in emerging mental illness in teens and young adults. Her expertise is in early stages of psychotic and bipolar disorders, along with anxiety and obsessive compulsive disorders. Dr...

Elizabeth Liebson, MD, is a psychiatrist at the Schizophrenia and Bipolar Disorder Inpatient Program, dividing her time between clinical work and teaching psychiatry residents and medical students. She is particularly interested in phenomenology and evaluation of first breaks. Dr. Liebson has been a...

At McLean, Steven Gans, MD is an attending psychiatrist at the Community Reintegration Unit, leading a team-based approach to the acute management of patients with serious mental illness. His other interests involve the teaching and practice of psychotherapy. Dr. Gans is an active teacher...

Dr. Regan Patrick received his PhD in psychology from McMaster University, where his research examining the cognitive and neural mechanisms of schizophrenia was funded by the prestigious Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR). He went on to complete...

Julie M. McCarthy, PhD, is a clinician-scientist in the Division of Psychotic Disorders. Her research aims to identify neurobiological and psychosocial treatment targets and develop/evaluate treatments for individuals and families experiencing co-occurring psychotic and substance use disorders. She...

Laura Strong, LICSW, currently works as a clinical team manager at Appleton, within the Division of Psychotic Disorders at McLean Hospital. Prior to joining Appleton, Ms. Strong worked in several other departments, in both clinical and research roles, including the Psychiatric Neurotherapeutics...

Jeanne McElhinney, MS, RN, BC, is the nurse director for Appleton and the Schizophrenia and Bipolar Disorder Inpatient Program. Ms. McElhinney began her career at McLean Hospital in 1986 and her passion for nursing continues to this day. Her leadership and professionalism has garnered her numerous...

Justin T. Baker, MD, PhD, is the scientific director of the McLean Institute for Technology in Psychiatry (ITP) and director of the Laboratory for Functional Neuroimaging and Bioinformatics at McLean Hospital. He is also an assistant professor of psychiatry at Harvard Medical School. Dr. Baker’s...